Longitudinal Models for Quantifying Disease and Therapeutic Response in Multiple Sclerosis
Treatment of patients with multiple sclerosis (MS) and development of new therapies have been challenging due to the disease complexity and slow progression, and the limited sensitivity of available clinical outcomes. Modeling and simulation has become an increasingly important component in drug dev...
Main Author: | Novakovic, Ana M. |
---|---|
Format: | Doctoral Thesis |
Language: | English |
Published: |
Uppsala universitet, Institutionen för farmaceutisk biovetenskap
2017
|
Subjects: | |
Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-316562 http://nbn-resolving.de/urn:isbn:978-91-554-9836-8 |
Similar Items
-
Benefits of Non-Linear Mixed Effect Modeling and Optimal Design : Pre-Clinical and Clinical Study Applications
by: Ernest II, Charles
Published: (2013) -
Pharmacometric Models in Anesthesia and Analgesia
by: Björnsson, Marcus
Published: (2013) -
Non-linear mixed effect models for the relationship between fasting plasma glucose and weight loss.
by: Evbjer, Ellen
Published: (2013) -
Effekter av en suboptimal läkemedelsförsörjning
by: Bourner, André
Published: (2017) -
The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study
by: Mehrdokht Mazdeh, et al.
Published: (2018-11-01)